• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cell cycle effects of iron depletion on T-47D human breast cancer cells.

作者信息

Reddel R R, Hedley D W, Sutherland R L

出版信息

Exp Cell Res. 1985 Dec;161(2):277-84. doi: 10.1016/0014-4827(85)90085-0.

DOI:10.1016/0014-4827(85)90085-0
PMID:2998833
Abstract

T-47D human breast cancer cells grown in culture medium containing low concentrations of fetal calf serum (FCS) proliferated very slowly, with an accumulation of cells in the G2 phase of the cell cycle, increased polyploid cells, and increased expression of transferrin receptors. Cell proliferation was stimulated by the addition of human transferrin or ammonium ferric citrate to the medium. Growth inhibition and accumulation of G2-phase cells could also be produced in T-47D cells grown in medium containing 10% FCS by the addition of the iron chelator, desferrioxamine. It is concluded that cellular deprivation of iron and/or transferrin is the major cause of reduced proliferation rates and G2-phase arrest which accompany the culture of these cells in medium supplemented with low concentrations of FCS.

摘要

相似文献

1
Cell cycle effects of iron depletion on T-47D human breast cancer cells.
Exp Cell Res. 1985 Dec;161(2):277-84. doi: 10.1016/0014-4827(85)90085-0.
2
Regulation of transferrin receptor synthesis by human cytotrophoblast cells in culture.培养的人细胞滋养层细胞对转铁蛋白受体合成的调节
Eur J Obstet Gynecol Reprod Biol. 1996 Apr;65(2):231-4. doi: 10.1016/0301-2115(95)02368-2.
3
The in vitro response of human tumour cells to desferrioxamine is growth medium dependent.人肿瘤细胞对去铁胺的体外反应取决于生长培养基。
Cell Prolif. 1993 Jan;26(1):77-88. doi: 10.1111/j.1365-2184.1993.tb00008.x.
4
The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells.去铁胺对人白血病细胞转铁蛋白受体、细胞周期及生长速率的影响。
Biochem J. 1986 May 15;236(1):243-9. doi: 10.1042/bj2360243.
5
Replacement of transferrin by simple iron compounds for MDCK cells grown and subcultured in serum-free medium.在无血清培养基中生长和传代培养的MDCK细胞中,用简单铁化合物替代转铁蛋白。
In Vitro Cell Dev Biol Anim. 1996 Sep;32(8):451-3. doi: 10.1007/BF02723044.
6
Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions.在不同铁供应条件下,去铁胺对淋巴细胞系生长的抑制作用。
Folia Biol (Praha). 1993;39(1):29-39.
7
Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.转铁蛋白、铁及转铁蛋白受体在髓系白血病细胞生长中的作用。抗转铁蛋白受体单克隆抗体的研究
J Clin Invest. 1985 Mar;75(3):1061-7. doi: 10.1172/JCI111768.
8
Effect of cellular iron concentration on iron uptake by hepatocytes.细胞铁浓度对肝细胞铁摄取的影响。
Am J Physiol. 1990 Oct;259(4 Pt 1):G611-7. doi: 10.1152/ajpgi.1990.259.4.G611.
9
Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate.黑色素瘤细胞从转铁蛋白摄取铁的两种机制。去铁胺和柠檬酸铁铵的作用。
J Biol Chem. 1992 Jul 15;267(20):13972-9.
10
The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells.去铁胺和柠檬酸铁铵对人黑色素瘤细胞膜铁结合成分摄取铁的影响。
Biochim Biophys Acta. 1992 Jan 31;1103(2):275-80. doi: 10.1016/0005-2736(92)90097-6.

引用本文的文献

1
Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells.在胰岛素受体缺陷细胞中,胰岛素通过I型胰岛素样生长因子受体促进乳腺癌细胞生长。
Exp Cell Res. 2024 Jan 1;434(1):113862. doi: 10.1016/j.yexcr.2023.113862. Epub 2023 Nov 28.
2
A Novel Ferroptosis-Related Gene Signature Predicts Overall Survival of Breast Cancer Patients.一种新型铁死亡相关基因特征可预测乳腺癌患者的总生存期。
Biology (Basel). 2021 Feb 14;10(2):151. doi: 10.3390/biology10020151.
3
Targeting ferroptosis in breast cancer.
针对乳腺癌中的铁死亡
Biomark Res. 2020 Nov 5;8(1):58. doi: 10.1186/s40364-020-00230-3.
4
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells.抗肿瘤药物Didox在肝癌细胞中作为铁螯合剂发挥作用。
Pharmaceuticals (Basel). 2019 Sep 2;12(3):129. doi: 10.3390/ph12030129.
5
Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.铁稳态的调节因子:新陈代谢、细胞死亡和疾病中的新角色
Trends Biochem Sci. 2016 Mar;41(3):274-286. doi: 10.1016/j.tibs.2015.11.012. Epub 2015 Dec 23.
6
Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells.铁通过线粒体依赖途径改变卵巢癌细胞的细胞存活情况。
Biochem J. 2015 Mar 1;466(2):401-13. doi: 10.1042/BJ20140878.
7
Iron deprivation in cancer--potential therapeutic implications.癌症中的铁剥夺——潜在的治疗意义。
Nutrients. 2013 Jul 24;5(8):2836-59. doi: 10.3390/nu5082836.
8
Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.膳食铁与储存铁作为乳腺癌风险的预测因素:上海的一项巢式病例对照研究。
Int J Cancer. 2009 Sep 1;125(5):1110-7. doi: 10.1002/ijc.24404.
9
Ruthenium ammine complexes as electron acceptors for growth stimulation by plasma membrane electron transport.钌氨配合物作为质膜电子传递促进生长的电子受体。
J Bioenerg Biomembr. 1987 Feb;19(1):69-81. doi: 10.1007/BF00769733.